ASSOCIATION BETWEEN ADMISSION MEAN ARTERIAL PRESSURE AND THE DEVELOPMENT OF CONTRAST-ASSOCIATED ACUTE KIDNEY INJURY WITHIN THE FIRST 72 HOURS IN PATIENTS WITH NSTEMI

Read full text
Authors: Aykut Bulu, Omer Isik, Mehmet Ali Kobat
Cited by: 1

Abstract

Introduction: Contrast-associated acute kidney injury (CI-AKI) is a frequent and clinically important complication after percutaneous coronary intervention (PCI), particularly in hemodynamically unstable patients with non–ST-elevation myocardial infarction (NSTEMI). Mean arterial pressure (MAP) is a key determinant of renal perfusion, yet the impact of admission MAP on CI-AKI development in NSTEMI patients undergoing PCI has not been clearly established. To investigate the relationship between admission MAP and the development of CI-AKI within the first 72 hours after PCI in patients with NSTEMI. Methods: This single-center, retrospective observational study included 150 consecutive patients hospitalized with NSTEMI who underwent PCI between January and December 2025. Admission systolic and diastolic blood pressures were obtained from emergency department triage records and MAP was calculated using the standard formula (MAP = [SBP + 2×DBP]/3). CI-AKI was defined according to KDIGO criteria as an increase in serum creatinine ≥0.3 mg/dL or ≥50% from baseline within 72 hours after contrast exposure. Patients were divided into two groups: those who developed CI-AKI (n=62, 41.3%) and those who did not (n=88, 58.7%). Non-parametric tests and Spearman correlation analysis were used. Results: The overall mean MAP was 88.99±27.44 mmHg. Patients who developed CI-AKI had significantly lower admission MAP compared with those without CI-AKI (60.33±3.95 vs. 109.18±16.76 mmHg; p

Fields of Study & Subjects

Acute Kidney Injury Research Chronic Kidney Disease and Diabetes Trauma Hemostasis Coagulopathy Resuscitation

Publication details

Journal / source
Eskisehir Medical Journal Eskisehir City Hospital
Publisher
Eskisehir Medical Journal, Eskisehir City Hospital
Publication date
4 March 2026
Language
EN